Association of HER-2/CEP17 Ratio and HER-2 Copy Number With pCR Rate in HER-2-Positive Breast Cancer After Dual-Target Neoadjuvant Therapy With Trastuzumab and Pertuzumab

OBJECTIVE: To explore the correlation between HER-2 status and pathological complete response (pCR) in HER-2-positive breast cancer after dual anti-HER-2 neoadjuvant therapy with trastuzumab and pertuzumab. METHODS: A total of 57 HER-2-positive breast cancer patients admitted to the Second Affiliate...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fanfan, Ju, Qian, Gao, Cong, Li, Jingjing, Wang, Xiaolei, Yan, Min, Zhang, Liying, Huang, Meiling, Long, Qihe, Jin, Xiangting, Li, Nanlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931257/
https://www.ncbi.nlm.nih.gov/pubmed/35311143
http://dx.doi.org/10.3389/fonc.2022.819818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931257/
https://www.ncbi.nlm.nih.gov/pubmed/35311143
http://dx.doi.org/10.3389/fonc.2022.819818

Ejemplares similares